![Hugh MacNaught](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 29 299 $ in data 30/06/2026
Mr. Hugh MacNaught is a President, Chief Executive Officer & Director at VentriPoint Diagnostics Ltd. and a Chief Executive Officer at Nanologix Research, Inc. He is on the Board of Directors at VentriPoint Diagnostics Ltd. Mr. MacNaught was previously employed as an Executive Vice President by biOasis Technologies, Inc.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 08/07/2026 | 375.634 ( 0,2% ) | 29 299 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| VENTRIPOINT DIAGNOSTICS LTD. | Amministratore Delegato | 05/02/2024 |
Nanologix Research, Inc. | Amministratore Delegato | - |
| Società | Posizione | Fine |
|---|---|---|
| VENTRIPOINT DIAGNOSTICS LTD. | Direttore/Membro del Consiglio | 01/10/2020 |
| BIOASIS TECHNOLOGIES INC. | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 3 |
|---|---|
VentriPoint Diagnostics Ltd.
 VentriPoint Diagnostics Ltd. Medical SpecialtiesHealth Technology Manufactures cardiac imaging systems | Health Technology |
biOasis Technologies, Inc.
 biOasis Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapeutic drug delivery for the treatment of neurological diseases and disorders | Health Technology |
Nanologix Research, Inc. |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
